Glycosaminoglycan anticoagulant

This page covers all Glycosaminoglycan anticoagulant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Antithrombin III, Heparin cofactor II.

Targets

Antithrombin III, Heparin cofactor II

Marketed (1)

• use of sulodexide orally only · Sun Yat-sen University · Cardiovascular
  Sulodexide is a glycosaminoglycan that enhances fibrinolysis and inhibits thrombosis by modulating coagulation and fibrinolytic pathways.

Patent intelligence

• glycosaminoglycan anticoagulant patent landscape — aggregated cliff calendar, attackable patents, originator estates